Temasek subsidiary Heliconia ceases to be substantial shareholder of Asian Healthcare Specialists
Temasek subsidiary Heliconia has ceased to be a substantial shareholder of Asian Healthcare Specialists, the healthcare company said Monday.
Temasek subsidiary Heliconia has ceased to be a substantial shareholder of Asian Healthcare Specialists, the healthcare company said Monday.
DBS and Temasek entered a deal to launch a US$500M growth-stage debt financing platform to be called EvolutionX Debt Capital.
Entities which announced SGX debt listing confirmations on Wednesday, 28 July 2021: Republic of Indonesia, Vertex Venture and Nonghyup Bank.
Temasek priced US$2.5 billion in notes across 10-year, 20-year and 40-year tranches, Singapore’s state-owned investment company said Tuesday.
Singapore companies which may be in focus on Tuesday, 27 July 2021: CDL Hospitality Trusts, Keppel DC REIT, KORE, LMIRT and ST Engineering.
Temasek plans to launch a three-tranche offering of 10-year, 20-year and 40-year U.S. dollar bonds, the state-owned investment company said Monday.
Temasek holds 2.68 percent of vaccine developer Jiangsu Recbio Technology, or 12 million pre-listing shares, according to the IPO prospectus.
Temasek subsidiary Vertex Ventures HC co-led, with Treo Ventures, medical device player Neuspera Medical’s US$65M series C funding round.
Microbial nitrogen fertilizer company Pivot Bio closed a US$430M series D funding round led by DCVC and Temasek, the company said Monday.
WebMD, part of Temasek-backed Internet Brands, has acquired The Wellness Network, which provides point-of-care, video education for patients.
The EPF Board of Malaysia acquired an additional 64,900 shares in UOA Development, bringing its total holding to a 10.18 percent stake.
Temasek holds 22.13M shares of U.S.-listed Intapp, or a 37.7% stake, according to a filing to U.S. securities regulators Monday.